Genentech Shortens Plant Deployment By 60% With Modular Emerson Automation Platform

Valspec’s Nimit Amipara, together with Genentech’s Tiffany Button, discussed the ambitious new validation processes that trimmed plant completion from five or more years to only two and a half. Genentech and Valspec, a provider of system validation and lifecycle services, implemented an innovative commissioning and qualification strategy based on their detailed knowledge of Emerson’s solutions and industry best practices.

 

Key Takeaways:

• Accelerated Time-to-Market: Integrated Emerson solutions compressed project timelines from 5-10 years to 2.5 years, enabling faster clinical delivery and competitive advantage.
• Scalable Template for Future Sites: The CSC's standardized platform creates a replicable design that dramatically reduces complexity and cycle time for deploying additional facilities.
• Compliance-Focused Efficiency: A risk-based validation strategy maintained regulatory standards while eliminating redundant oversight and accelerating go-live.